Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of both BETAXON and AZOPT in
pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve
weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at
each visit. Patients will have a dilated fundus exam and corneal measurements taken at first
and last visit.